asbestos lawyers - Worthington & Caron, PC

Over $2.5 billion

obtained for mesothelioma patients & families

In The News

Statins May Increase Effectiveness in Immunotherapy Treatment for Mesothelioma

A December 2020 study revealed that high doses of statins (lipid-lowering medications) have a synergistic effect on PD-1 immunotherapy treatments yielding better clinical outcomes for pleural mesothelioma and advanced non-small cell lung cancer patients.

The study involved statins taken in combination with Opdivo by patients receiving second or third-line treatment. The response rate was 22% for patients receiving Opdivo and statins vs. 6% for those not receiving statins. Progression-free survival was 6.7 months vs. 2.3 months respectively. A control group of patients who received statins with chemotherapy no increase in response or survival rates.

Get Empowered

We put your medical and personal needs first and provide compassionate representation.

Please enter the captcha above: